Stocks · Health care · Pharmaceutical Preparations

ARDELYX, INC.

ARDX Clue Score56
United States Fiscal year ends December CIK 0001437402 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Raab
15 Jul 2026
President & CEO
Sold after exercise
41,668
$5.06
$210.92K
Laura A Williams
18 Jun 2026
Chief Patient Officer
Sold after exercise
81,898
$5.99
$490.49K
Michael Raab
15 Jun 2026
President & CEO
Sold after exercise
41,666
$5.67
$236.35K
Michael Raab
15 May 2026
President & CEO
Sold after exercise
41,666
$6.28
$261.61K
Michael Raab
15 Apr 2026
President & CEO
Sold after exercise
41,668
$6.29
$261.95K
Michael Raab
16 Mar 2026
President & CEO
Sold after exercise
41,666
$5.84
$243.33K
Michael Raab
24 Feb 2026
President & CEO
Sold after exercise
41,666
$6.26
$260.62K
Laura A Williams
8 Jan 2026
Chief Patient Officer
Sold after exercise
50,000
$6.98
$348.90K
Laura A Williams
26 Aug 2025
Chief Patient Officer
Sold after exercise
30,000
$6.12
$183.63K
Laura A Williams
26 Aug 2025
Chief Patient Officer
Sold after exercise
50,000
$6.12
$306.05K
Michael Raab
2 May 2025
President & CEO
Sold after exercise
41,666
$4.25
$177.17K
Michael Raab
4 Apr 2025
President & CEO
Sold after exercise
41,666
$4.59
$191.15K
Michael Raab
7 Mar 2025
President & CEO
Sold after exercise
41,668
$5.36
$223.20K
Michael Raab
31 Jan 2025
President & CEO
Sold after exercise
41,666
$5.36
$223.35K
Michael Raab
7 Jan 2025
President & CEO
Sold after exercise
41,666
$5.31
$221.31K
Michael Raab
10 Dec 2024
President & CEO
Sold after exercise
25,000
$5.26
$131.62K
David P. Rosenbaum
6 Nov 2024
Chief Development Officer
Sold after exercise indirect
27,171
$6.10
$165.74K
David P. Rosenbaum
4 Nov 2024
Chief Development Officer
Sold after exercise indirect
27,172
$5.95
$161.67K
Michael Raab
28 Oct 2024
President & CEO
Sold after exercise
25,000
$5.91
$147.74K
Michael Raab
11 Sep 2024
President & CEO
Sold after exercise
35,000
$5.61
$196.40K
David P. Rosenbaum
20 Aug 2024
Chief Development Officer
Sold after exercise indirect
20,507
$6.00
$123.04K
Michael Raab
29 Jul 2024
President & CEO
Sold after exercise
30,000
$5.64
$169.31K
Michael Raab
13 Jun 2024
President & CEO
Sold after exercise
35,000
$6.65
$232.74K
Laura A Williams
5 Jun 2024
Chief Medical Officer
Sold after exercise
100,000
$7.13
$712.50K
Laura A Williams
5 Jun 2024
Chief Medical Officer
Sold after exercise
45,000
$7.12
$320.58K
Elizabeth A Grammer
6 May 2024
See Remarks
Sold after exercise
219,937
$8.88
$1.95M
Elizabeth A Grammer
6 May 2024
See Remarks
Sold after exercise
64,233
$8.87
$569.84K
Robert Ora Felsch
6 May 2024
See Remarks
Sold after exercise
55,000
$8.80
$484.00K
Robert Ora Felsch
6 May 2024
See Remarks
Sold after exercise
152,988
$8.81
$1.35M
Laura A Williams
3 May 2024
Chief Medical Officer
Sold after exercise
39,949
$8.35
$333.57K
Michael Raab
29 Apr 2024
President & CEO
Sold after exercise
30,000
$6.40
$192.06K
Justin A Renz
26 Dec 2023
Chief Financial Officer
Sold after exercise
225,000
$6.36
$1.43M
Robert Blanks
23 Jun 2023
See Remarks
Sold after exercise
33,333
$3.63
$121.04K
Showing 250 of 443 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 508
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 44
Sales at will 346
Transactions with no price 0
Shares from compensation/vesting 41,416,740
Sales filed before the plan box existed 194
History held since 18 Jun 2014